9Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer [J]. Clin Oncol, 1998,16(8):2672-2685.
10Dash N, Chafin SH, Johnson RR, et al. Usefulness of tissue marker clips in patients undergoing neoadjuvant chemotherapy for breast cancer[J]. A JR Am J Roentgenol, 1999,173(4): 911-917.
3Verrelle P, Meissonnier F, Fonck Y, et al. Clinical relevance of immuno- histochemical detection of multidrug resistance P-glycoprotein in breast carcinoma[ J]. J Natl Cancer Inst, 1991,83 ( 8 ) : 111 - 116.
4Xie Y, Xu K, Linn DE, et al. The 44kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resist- ant activity in hum an prostate cancer cells[ J ]. J Biol Chem, 2008,283 (6) :3349 - 3356.
5Huang J,Tan PH, Thiyagarajan J, et al. Glutathione S-transferase-pi in invasive breast cancer [ J ]. Mod Patho1,2003,16 (6) :558.
6Ates NA,Tamer L,Ates C,et al. Glutathione S-transferase M1 T1 ,Pig- enotypes and risk for development of colorectal cancer [ J ]. Biochem Genet,2005,43 (3) : 149 - 163.
7Musgrove EA, Hunter LJ, Lee CS, et al. Cyclin D1 overexpression in- duces progestin resistance in T-47D breast cancer ceils despite p27 ( Kipl ) association with cyclin E-Cdk2 [ J ]. J B iolChem,2001,27 ( 6 ) : 47675 - 47683.
8Dizdarevic S,Peters AM . Imaging of multidrug resistance in cancer [J ] . Cancer Imaging, 2011,11 : 1-8.
9Marquette C,Nabell L . Chemotherapy-resistant metastatic breast cancer.Curr Treat Options Oncol[J]. 2012,13(2) :263-275.
10Tahefi M, Mahjoubi F, Omranipour R. Effect of MDR1 polymorphism on muhidrug resistance expression in breast cancer patients . Gene Mol Res[ J ], 2010,9( 1 ) : 34-40.
